Akums Drugs & Pharmaceuticals Board Meeting Scheduled for November 13, 2025
Akums Drugs & Pharmaceuticals has announced that a meeting of its Board of Directors is scheduled for November 13, 2025. The meeting will…
ITI Limited Board to Consider Q2 FY26 Financial Results
ITI Limited has announced a meeting of its Board of Directors scheduled for November 13, 2025, to consider and approve the Un-Audited…
Poly Medicure Board Approves Unaudited Financial Results for Q2 & H1 2026
The Board of Directors at Poly Medicure has approved the unaudited financial results for the second quarter and first half of fiscal year…
SKF India Board Meeting Scheduled for November 14, 2025 to Approve Unaudited Financial Results
SKF India has announced a board meeting scheduled for November 14, 2025, to consider and approve the unaudited financial results for the…
Craftsman Automation Board Approves Unaudited Financial Results for Q2 2026
Craftsman Automation’s Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter and…
Ramkrishna Forgings Board to Consider Fundraising and Quarterly Results
Ramkrishna Forgings has announced a board meeting scheduled for November 12, 2025, to consider and approve the unaudited standalone and…
Patanjali Foods Board Approves Interim Dividend of ₹1.75 Per Share
Patanjali Foods has announced an interim dividend of ₹1.75 per equity share with a face value of ₹2 each, for the financial year 2025-26. The…
Max Healthcare Board to Consider Financial Results on November 14, 2025
The Board of Directors of Max Healthcare Institute Limited is scheduled to meet on Friday, November 14, 2025, to review and approve the…
Concord Biotech Board to Approve Q2 & H1 Unaudited Financial Results
Concord Biotech’s Board of Directors will convene on November 13, 2025, to review and approve the standalone and consolidated unaudited…
Valor Estate Board to Consider Quarterly Results and Preference Share Conversion
Valor Estate Limited has announced a board meeting scheduled for November 14, 2025, to review and approve the unaudited standalone and…